Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS ... discuss the array of existing and emerging classes of drugs that could benefit those with ACOS and share their ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

In clinical trials, treatment with the drug reduced ... not have a 200-microgram (mcg) dose for COPD. However, this dose may be prescribed for asthma. To learn about the dosage of Trelegy Ellipta ...

This roundup offers a look at the latest insights from the clinicians and researchers investigating chronic obstructive pulmonary disease and asthma.

After many trips to the doctor's office, five-year-old Burton Hayes's asthma was finally under control with a medication ...

Loneliness is a key risk factor for symptom exacerbations and hospitalizations in people with COPD, highlighting the need for ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

A high-tech device that can monitor medication use and compliance has ... and Adherium also sells the device directly to patients with asthma and COPD under a 510(k) over-the-counter clearance.

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...